Lupin Aims To Invalidate Ortho Birth Control Patent
Responding to a patent infringement suit brought by Ortho-McNeil-Janssen Pharmaceuticals Inc., India-based generic-drug maker Lupin Pharmaceuticals Inc. has asked a federal judge to invalidate Ortho's patent for contraceptive Tri-Cyclen Lo....To view the full article, register now.
Already a subscriber? Click here to view full article